Generics - Generics, Gastro-intestinals

Filter

Popular Filters

Actavis prevails in Lialda patent dispute in USA

Actavis prevails in Lialda patent dispute in USA

31-03-2014

US generics major Actavis says that the US Court of Appeals for the Federal Circuit has reversed a lower…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsShireUSA

Amneal debuts generic Esomeprazole strontium in USA

07-01-2014

Privately-held US generics drugmaker Amneal Pharmaceuticals has announced the launch of generic esomeprazole…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsMarkets & MarketingNexiumNorth AmericaUSA

Hanmi launches esomeprazole product in USA despite AstraZeneca litigation

Hanmi launches esomeprazole product in USA despite AstraZeneca litigation

18-12-2013

South Korea-based Hanmi Pharmaceutical has announced that Esomezol (esomeprazole strontium) for the treatment…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumEsomeprazole SodiumGastro-intestinalsGenericsHanmi PharmaceuticalLegalNexiumPharmaceuticalUSA

Zydus Cadila settles Asacol patent litigation in USA

11-12-2013

Zydus Cadila, one of India’s largest privately-held pharmaceuticals companies, and affiliate Zydus…

ActavisAsacol HDGastro-intestinalsGenericsNorth AmericaPatentsWarner ChilcottZydus Cadila

AstraZeneca wins damages from Apotex

AstraZeneca wins damages from Apotex

04-12-2013

Anglo-Swedish drug major AstraZeneca this morning said it welcomed the US District Court for the Southern…

ApotexAstraZenecaFinancialGastro-intestinalsGenericsNexium I.V.North AmericaPatentsPrilosec

Abraaj sells stake in Opalia Pharma to Recordati

05-11-2013

The Dubai-based Abraaj Group, an investor operating in global growth markets, has announced its full…

Abraaj GroupDermatologicalsGastro-intestinalsGenericsMergers & AcquisitionsOpalia PharmaRecordatiRespiratory and PulmonaryRest of the World

Impax Labs confirms patent challenge to Pfizer/UCB's Toviaz

04-07-2013

US specialty drugmaker Impax Laboratories (Nasdaq: IPXL) yesterday confirmed that it has initiated a…

Gastro-intestinalsGenericsImpax LaboratoriesNorth AmericaPatentsPfizerToviazUCB

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent

12-06-2013

Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Shire prevails in US Lialda patent dispute with Watson

10-05-2013

Ireland-headquartered drugmaker Shire's (LSE: SHP) subsidiary Shire Development has prevailed in its…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsPharmaceuticalShireWatson Pharmaceuticals

Prescription drug costs: USA versus UK

04-11-2012

In the USA, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who…

Cardio-vascularEuropeGastro-intestinalsGenericsNorth AmericaPharmaceuticalPricing

Researchers bust a gut to improve gastrointestinal disorders market

28-10-2012

Drugs to treat gastrointestinal disorders are due to see a significant price drop, as patents run out…

Gastro-intestinalsGenericsMarkets & MarketingPharmaceutical

Uptake of biosimilars will see Remicade and Humira sales decline in 2017

26-09-2012

The TNF-alpha inhibitors infliximab (Janssen Biotech/Merck/Mitsubishi Tanabe's Remicade) and adalimumab…

BiotechnologyGastro-intestinalsGenericsGlobalHumiraMarkets & MarketingRemicade

Pfizer links with SFJ Pharma for dacomitinib trial; settles with Mylan

10-09-2012

SFJ Pharmaceuticals Group, a global drug development group of companies which provides a unique co-development…

dacomitinibDetrol LAGastro-intestinalsGenericsLegalMylan LaboratoriesNorth AmericaOncologyPatentsPfizerPharmaceuticalResearchSFJ Pharmaceuticals

Watson debuts generic Nexium in Europe; Mylan launches Amidate copy in USA

08-08-2012

US generics firm Watson Pharmaceuticals (NYSE: WPI) said yesterday that its third-party business Specifar…

AmidateAstraZenecaEuropeGastro-intestinalsGenericsHospiraMarkets & MarketingMylan LaboratoriesNeurologicalNexiumNorth AmericaRegulationWatson Pharmaceuticals

Par Pharma acquires Handa's ANDA for generic Dexilant

23-04-2012

USA-based Par Pharmaceutical (NYSE: PRX) has entered into an exclusive acquisition and license agreement…

DexilantGastro-intestinalsGenericsHanda PharmaceuticalsLicensingNorth AmericaPar PharmaceuticalsTakeda Pharmaceuticals

Generic erosion will reduce BPH/male urinary tract drug market to $4 billion in 2010

20-11-2011

The market for therapies that treat benign prostatic hyperplasia (BPH) and associated lower urinary tract…

Gastro-intestinalsGenericsGlobalMarkets & MarketingPharmaceutical

Biosimilars of TNF-alpha inhibitors and pegylated IFN-alpha agents set to save health care systems $5.3 billion in 2020

04-10-2011

Biosimilar versions of tumor necrosis factor (TNF)-alpha inhibitors and pegylated interferon (IFN)-alpha…

Anti-Arthritics/RheumaticsBiotechnologyEuropeGastro-intestinalsGenericsMarkets & MarketingNorth America

Ranbaxy debuts first approved generic of Nexium in the UK

05-09-2011

The UK subsidiary of India largest drugmaker Ranbaxy (RANB: BO) says that it has successfully launched…

AstraZenecaEuropeGastro-intestinalsGenericsMarkets & MarketingNexiumRanbaxy Laboratories

Back to top